WP
TVTX icon

Woodline Partners’s Travere Therapeutics TVTX Stock Holding History

Woodline Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Sell
254,054
-48,612
-16% -$2.16M 0.04% 455
2026
Q1 		$8.99M Buy
302,666
+138,402
+84% +$4.14M 0.03% 540
2025
Q4 		$6.28M Buy
164,264
+74,936
+84% +$2.44M 0.02% 571
2025
Q3 		$2.13M Sell
89,328
-411,667
-82% -$7.74M 0.01% 726
2025
Q2 		$7.41M Sell
500,995
-728,783
-59% -$12.1M 0.04% 487
2025
Q1 		$22M Sell
1,229,778
-884,278
-42% -$17.9M 0.14% 213
2024
Q4 		$36.8M Sell
2,114,056
-2,226,284
-51% -$39.4M 0.25% 124
2024
Q3 		$60.7M Buy
4,340,340
+3,063,462
+240% +$31.9M 0.51% 45
2024
Q2 		$10.5M Buy
+1,276,878
New +$8.6M 0.1% 242
2024
Q1 		– Sell
-636,621
Closed -$5.72M – 637
2023
Q4 		$5.72M Sell
636,621
-1,513,944
-70% -$11M 0.06% 303
2023
Q3 		$19.2M Buy
2,150,565
+1,110,269
+107% +$15.7M 0.23% 137
2023
Q2 		$16M Sell
1,040,296
-399,403
-28% -$7.27M 0.19% 159
2023
Q1 		$32.4M Buy
1,439,699
+1,342,791
+1,386% +$28.5M 0.44% 65
2022
Q4 		$2.04M Sell
96,908
-171,267
-64% -$3.63M 0.03% 472
2022
Q3 		$6.61M Buy
+268,175
New +$6.93M 0.09% 250
2021
Q4 		– Sell
-145,918
Closed -$3.54M – 791
2021
Q3 		$3.54M Buy
+145,918
New +$2.68M 0.06% 308
2020
Q1 		– Sell
-281,423
Closed -$4M – 172
2019
Q4 		$4M Buy
+281,423
New +$3.59M 0.16% 96

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Woodline Partners's TVTX Position: Q2 2026 in Review

Woodline Partners reduced its Travere Therapeutics (TVTX) stake by 16% in Q2 2026, selling an estimated $2.16M and leaving 254,054 shares worth $14.4M. The position accounts for 0.04% of the portfolio, ranked #455.

Woodline Partners first reported a position in TVTX in Q4 2019 and has held it in 17 quarters since. The position peaked at $60.7M in Q3 2024. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Woodline Partners held 254,054 shares of Travere Therapeutics worth $14.4M as of Q2 2026.
  • Woodline Partners sold 48,612 Travere Therapeutics shares in Q2 2026, an estimated $2.16M.
  • Travere Therapeutics made up 0.04% of Woodline Partners's portfolio in Q2 2026, its #455 holding.
  • Woodline Partners first reported a position in Travere Therapeutics in Q4 2019 and has held it in 17 quarters since.
  • Woodline Partners's Travere Therapeutics position peaked at $60.7M in Q3 2024.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.